期刊文献+

Flutamide对前列腺癌细胞分化抑制因子1表达影响

EFFECT OF FLUTAMIDE ON THE EXPRESSION OF INHIBITOR OF DIFFERENTIATION 1 IN PROSTATE CANCER CELLS
下载PDF
导出
摘要 目的了解雄激素受体阻断剂Flutamide对前列腺癌细胞分化抑制因子1(ID1)表达的影响及意义。方法在培养的前列腺癌LNCaP和PC3细胞中分别加入Flutamide,用实时荧光定量反转录聚合酶链式反应(RTPCR)方法检测ID1mRNA相对定量表达;用Western Blotting方法检测ID1蛋白表达,以不加Flutamide细胞作为对照组。结果与对照组比较,Flutamide组LNCaP和PC3细胞ID1 mRNA相对定量明显减少,LNCaP细胞中ID1蛋白表达明显减少,差异有显著性(t=3.09~34.91,P〈0.05)。Flutamide组LNCaP中ID1 mRNA相对定量、ID1蛋白表达低于PC3细胞,差异有显著性(t=2.57、12.52,P〈0.05)。结论 Flutamide能抑制前列腺癌细胞中ID1的表达,ID1的表达可能受雄激素-受体途径的调控。 Objective To investigate the effect of Flutamide, an androgen-receptor blocker, on the expression of inhibi- tor of differentiation 1 (ID1) in prostate cancer cells. Methods Androgen-dependent and independent prostate cancer cell line- LNCaP and PC3 cells were treated with Flutamide. The relative quantity of ID1 mRNA was detected by SYBR Green I-based real time reverse transcription polymerase chain reaction (RT-PCR). The protein expression of ID1 was detected by Western Blotting. The cells that without Flutamide served as control, group. Results Compared with the control group, the relative quantity of ID1 mRNA in LNCaP and PC3 in Flutamide group significantly decreased (t= 3.09-34,.91, P 〈0.05). The quantity of ID1 mRN A in LNCaP cells was obviously decreased compared with that in PC3 ceils after treated by Flutamide (t = 2.57,12.52 P〈0.05). Con- clusion Flutamide can inhibit the expression of ID1 in prostate cancer cells, suggesting that the expression of ID1 may be regula- ted by androgen-receptor pathway.
出处 《青岛大学医学院学报》 CAS 2015年第1期94-96,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 前列腺肿瘤 LNCAP细胞 PC3细胞 细胞分化抑制因子1 FLUTAMIDE prostatic neoplasms LNCaP cells PC3 cells inhibitor of differentiation 1 Flutamide
  • 相关文献

参考文献8

  • 1REDRADO M, BODEGAS E, VILLARO A C, et al. Spatial- temporal protein expression of inhibitor of differentiation-1 (Idl) during fetal embryogenesis and in different mouse and human cancer types[J]. Histology and Histopathology, 2013, 28(8) : 1029-1040.
  • 2刘玉波,于小玲,赵辉.前列腺癌组织BMP2表达及其与DIF-1的相关性[J].齐鲁医学杂志,2011,26(2):114-115. 被引量:2
  • 3LIVAK K J, SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (--Delta Delta C(T)) method[J]. Methods (San Diego, Ca- lif), 2001,25(4) :402-408.
  • 4ASIRVATHAM A J, SCHMIDT M A, CHAUDHARY J. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells[J]. The Pros- tate, 2006,66(9) :921-935.
  • 5LIMAYE A M, ASANGANI I, KALYANI T, et al. Changes in gene expression following androgen receptor blockade is not equivalent to androgen ablation by castration in the rat ventral prostate[J]. Journal of Biosciences, 2008,33 (2) : 209-220.
  • 6LING M T, WANG X H, LEE D T, et al. Id-1 expression in- duces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF R) [J]. Carcinogenesis, 2004,25 (4) : 517-525.
  • 7XU B, SUN Y H, TANG G S, et al. Id-1 expression in andro- gen-dependent prostate cancer is negatively regulated by an- drogen through androgen receptor[J]. Cancer Letters, 2009, 278(2) ,220-229.
  • 8AO J P, MENG J P, ZHU LPPEI, et al. Activation of andro- gen receptor induces ID1 and promotes hepatocellular carcino- ma cell migration and invasion[J]. Molecular Oncology, 2012, 6(5) :507-515.

二级参考文献9

  • 1李泽良,刘仁辉,孔垂泽.骨形态发生蛋白2和4在前列腺癌中的表达[J].中华男科学杂志,2006,12(2):126-128. 被引量:2
  • 2XU J,ROGERS M B.Modulation of bone morphogenetic protein (BMP) 2 gene expression by Spl transcription factors[J].Gene,2007,392(1-2):221-229.
  • 3BOBINAC D,MARIC I,ZORICIC S,et al.Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer[J].Croat Med J,2005,46(3):389-396.
  • 4CLEMENT J H,MARR N,MEISSNER A,et al.Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7[J].J Cancer Res Clin Oncol,2000,126(5):271-279.
  • 5TANG J,GORDON G M,NICKOLOFF B J,et al.The helix-loop-helix protein ID1 delays onset of replicative senescence in human endothelial ceUs[J].Lab Invest,2002,82(8):1073-1079.
  • 6OUYANG X S,WANG X,LEE D T,et al.Over expression of ID1 in prostate cancer[J].J Urol,2002,167(6):2598-2602.
  • 7YU X,XU X,HAN B,et al.Inhibitor of DNA binding-1 overexpression in prostate cancer:relevance to tumor differentiation[J].Pathol Oncol Res,2009,15 (1):91-96.
  • 8DU Y,YIP H.Effects of bone morphogenetic protein 2 on ID expression and neuroblastoma cell differentiation[J].Differentiation,2010,79 (2):84-92.
  • 9周晓彬,纪新强,徐莉.PPMS 1.5统计软件的功能及其应用[J].青岛大学医学院学报,2009,45(1):91-93. 被引量:284

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部